Prognostic Factors for 30-day Mortality after Hip Fracture in the Elderly
PDF
Cite
Share
Request
Clinical Research
VOLUME: 36 ISSUE: 2
P: 109 - 117
August 2026

Prognostic Factors for 30-day Mortality after Hip Fracture in the Elderly

Anatol J Gen Med Res 2026;36(2):109-117
1. Atatürk University Faculty of Medicine, Department of Internal Medicine, Division of Geriatrics, Erzurum, Türkiye
2. Atatürk University Faculty of Medicine, Department of Orthopedic Surgery, Erzurum, Türkiye
3. Erzurum Training and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Erzurum, Türkiye
No information available.
No information available
Received Date: 03.02.2025
Accepted Date: 25.10.2025
Online Date: 31.08.2026
Publish Date: 31.08.2026
PDF
Cite
Share
Request

Abstract

Objective

In older adults, hip fractures lead to disability, diminished life quality, and increased socioeconomic burden and risk of death. This study aimed to evaluate the prognostic determinants of survival within a geriatric cohort following hip fracture.

Methods

We conducted a retrospective chart review of individuals aged 60 and above admitted with hip fractures to a tertiary academic orthopedic department from January 2013 through January 2024. Our analysis integrated baseline demographic and clinical profiles,  fracture etiology, and anatomical site. Furthermore, we assessed surgical variables (timing and specific techniques employed), postoperative adverse events, total hospitalization duration, and mortality status at one month post-injury.

Results

A total of 250 older adults (median age: 80 years, range: 60-110, 62.4% women) constituted the study sample. The 30-day mortality rate was 6.8% (n=17). Patients in the non-surviving group were notably older (p=0.021) and more likely to have dementia (p=0.014) than those who survived. Femoral neck fractures were associated with improved survival (p=0.004), whereas pertrochanteric fractures were associated with increased mortality (p<0.001). Admission laboratory data showed that non-survivors had depressed lymphocyte counts and elevated serum creatinine and blood urea nitrogen concentrations. Subsequent multivariate logistic regression identified pre-existing dementia (odds ratio=4.12) and pertrochanteric fracture location (odds ratio=15.87) as independent predictors of early mortality.

Conclusion

Early mortality following a hip fracture among geriatric patients was strongly predicted by the presence of  comorbid dementia, pertrochanteric fracture, and admission lymphopenia. Recognizing these baseline clinical vulnerabilities is critical for implementing vigilant, targeted perioperative care protocols.

Keywords:
Elderly, hip fracture, mortality, prognostic factors, risk factors

Introduction

The prevalence of osteoporosis rises with advancing age due to a combination of altered bone microarchitecture, diminished osteoblastic function, and heightened osteoclastic activity. Furthermore, advanced age is associated with an increased risk of falls secondary to visual and balance impairments, frailty, polypharmacy, gait instability, and sarcopenia. Consequently, osteoporotic individuals are at increased risk of hip fractures(1), which are among the most important orthopedic challenges in the geriatric population(2). Beyond increasing mortality risk and socioeconomic burden, these fractures severely compromise quality of life and result in serious disability. With the ongoing aging of the global population, projections indicate a continuous climb in the yearly incidence of these injuries(3, 4), with estimates anticipating up to 6.25 million cases by the year 2050(5).

Within the first 12 months following a hip fracture, the observed fatality rate in the geriatric population ranges from 14% to 36%(6). However, evidence suggests that three-quarters of hip fracture-related deaths are associated with preexisting comorbidities rather than the fracture itself(7). Additional variables shown to elevate post-fracture mortality risk include male sex, older age, institutionalization (such as nursing home residency), malnutrition elevated American Society of Anesthesiologists (ASA) classification, and specific conditions such as diabetes, dementia, cancer, and ischemic heart disease(8-10). Typically, clinical guidelines recommend operative management of these fractures in elderly patients within 48 hours. While prompt surgical intervention is generally favored to mitigate both morbidity and mortality in the majority of cases, the effect of surgical timing on mortality is debated in the literature(11-13).

While the broader literature contains numerous epidemiological investigations of hip fractures, there is a notable scarcity of data specifically addressing post-fracture mortality among older adults in the national context. The primary objective of this study was to identify prognostic factors associated with survival in a cohort of older patients with hip fracture.

Materials and Methods

This cross-sectional, retrospective study included geriatric patients (age 60 and above) who were admitted with hip fractures to the orthopedics department of a tertiary academic medical hospital between January 2013 and January 2024. Patients who met the above criteria and received a radiological diagnosis (via computed tomography and/or direct X-ray) of femoral neck, pertrochanteric, or subtrochanteric fractures were eligible for inclusion. Patients were excluded if they refused hospitalization, presented with a pathological fracture, or had a documented prior hip fracture.

Patient files and electronic databases were reviewed to extract a comprehensive set of variables. These included survival status at 30 days, duration of inpatient stay, occurrence of postoperative adverse events, need for perioperative blood product transfusion, estimated blood loss, anesthesia modality (general, spinal, or epidural), ASA classification, surgical technique, date of the fracture and subsequent surgery, time from injury to operation, presence of concomitant non-hip fractures, anatomical location and etiology of the hip injury, osteoporosis subtype and bone mineral density metrics, pharmacological profile (type and quantity of medications), existing chronic comorbidities, and baseline demographic details. Mortality outcomes were verified through the national death registry, and postoperative survival times were recorded.

Osteoporotic conditions were grouped into primary and secondary. Traumatic etiology was dichotomized into high-energy and low-energy mechanisms. We stratified postoperative adverse events into surgical and metabolic categories. Specifically, surgical complications encompassed surgical site infections, hip dislocations, and stress fractures, whereas metabolic complications included episodes of delirium, acute kidney injuries, cerebrovascular accidents, pulmonary embolisms, pneumonias, and respiratory failures. To quantify the cumulative impact of concurrent illnesses, we utilized the modified Charlson comorbidity index (mCCI). The mCCI was developed by Charlson et al.(14) in 1987 to estimate the 10-year mortality risk by measuring the burden of comorbid disease.

Additionally, to assess potential associations with mortality, a wide array of admission laboratory parameters was analyzed. This panel comprised levels of gamma-glutamyl transferase, alkaline phosphatase, magnesium, phosphorus, calcium, potassium, glucose, sodium, blood urea nitrogen (BUN), albumin, total protein, lactate dehydrogenase, alanine transaminase, aspartate transaminase, hematocrit, and hemoglobin, and counts of platelets, lymphocytes, neutrophils, and total white blood cells.

Prior to the commencement of the study, formal approval was obtained from the Clinical Research Ethics Committee of Atatürk University Faculty of Medicine (approval no: 06, date: 21.02.2024).

Statistical Analysis

Data analysis was conducted in IBM SPSS Statistics version 21.0 (IBM Corp). The normality of distributions of continuous variables was assessed using the Kolmogorov-Smirnov test. For parametric data, the Student’s t-test was used to perform pairwise comparisons between independent groups; for non-parametric data, the Mann-Whitney U test was used. Associations among categorical variables were examined using chi-square tests. To evaluate predictors of early mortality, parameters that achieved statistical significance in univariate analyses were included in a multivariate logistic regression analysis (backward LR model with entry and removal criteria set at 0.05 and 0.10, respectively). The threshold for statistical significance was defined as a p-value below 0.05.

Results

A total of 250 older adults (aged 60 years and older) with hip fractures were analyzed. Women constituted 62.4% (n=156) of the cohort, and the median age was 80 years (range: 60-110). The 30-day mortality rate was 6.8% (n=17). Surgical intervention was the primary treatment modality for the majority of patients (97.2%, n=243).

Table 1 details the distribution of baseline demographics, comorbidities, and hip fracture characteristics, stratified by early mortality status. Compared with surviving patients, non-survivors were older (p=0.021) and more likely to have pre-existing dementia (p=0.014). Furthermore, the non-surviving group exhibited a higher median mCCI score (p=0.030). Anatomical fracture site was also significantly associated with 30-day survival outcomes, with femoral neck fractures associated with better survival (p=0.004) and pertrochanteric fractures associated with higher mortality (p<0.001). Individuals managed conservatively (without surgery) exhibited a higher rate of early mortality than those who underwent operative repair (p=0.008).

Table 2 outlines the relationship between 30-day mortality and perioperative factors, including the need for red-cell transfusion, anesthetic modality, time to surgery, and postoperative adverse events. Overall, 54 patients (22.2%) experienced at least one postoperative medical or surgical complication; of these, 7 developed multiple complications. The rate of early mortality was higher in patients who experienced postoperative adverse events (64.3% vs. 20.1%; p<0.001). Figure 1 illustrates the frequency of complications according to 30-day survival status. The most common surgical complication was surgical site infection (n=12), while the most common medical complications were pulmonary embolism (n=15) and acute kidney injury (n=16).

Table 3 summarizes the association between 30-day mortality and admission laboratory results. Non-survivors had significantly lower lymphocyte levels (p=0.003) and higher serum concentrations of creatinine (p=0.030) and BUN (p=0.006).

To identify independent predictors of early mortality, we constructed a multivariate logistic regression model incorporating all variables that reached statistical significance in univariate testing (admission lymphocyte count, serum creatinine, serum BUN, surgical treatment, anatomical fracture site, dementia diagnosis, and patient age). As detailed in Table 4, this analysis identified pertrochanteric fracture location [odds ratio (OR)=15.87, p<0.001] and comorbid dementia (OR=4.12, p=0.021) as primary independent risk factors. Additionally, each single-unit decrease in baseline lymphocyte count correlated with a 0.2% increase in the odds of early mortality (OR=1.002, p=0.004). In contrast, operative treatment emerged as a robust protective factor, yielding a 97.7% reduction in the odds of mortality (OR=0.023, p<0.001).

Discussion

This study evaluated a cohort of 250 geriatric patients with hip fractures (median age 80 years; 62.4% women) to determine risk factors for early mortality. We determined that the odds of 30-day mortality were more than 4 times higher for patients with dementia and nearly 16 times higher for patients with pertrochanteric fracture. A lower lymphocyte count was also significant (0.2% lower odds per unit decrease in lymphocyte count). Conversely, surgical treatment reduced the odds of early mortality by 97.7%.

A previous prospective study showed that in older adults, new functional losses occur throughout the first year after a hip fracture(15).Other studies demonstrated that the prevalence of frailty increased with decreased mobility, impaired balance, decreased muscle strength, impaired cognitive function, malnutrition, reduced physical activity, and greater falls risk(16-19). In a cohort of women aged 65 and over, followed for 12 months post-hip fracture, elevated serum interleukin-6 levels were associated with persistent lower-extremity dysfunction. For patients with multiple pre-existing comorbidities, a hip fracture may trigger or accelerate frailty via inflammatory or immunological mechanisms, which can impact survival(20). In this study, we aimed to identify independent predictors of mortality risk among older patients in whom hip fracture is known to be associated with a poorer prognosis.

In our geriatric cohort, the observed 30-day mortality rate after hip fracture was 6.8%. This rate ranges between 5.4% and 14.3% in the published literature(21, 22). Furthermore, our analysis identified dementia in 22.8% of the study population. Past research has reported a wide variation in dementia prevalence (6.38% to 30%) among older adults with hip fracture, depending on variables such as genetic background, ethnicity, and demographic factors. Dementia is a known risk factor for frailty because it contributes to malnutrition, infection, and trauma, and it has also been linked to higher mortality after hip fracture(23, 24). Similarly, a review by Lai et al.(25) including 8.080 patients with dementia and 145.543 cognitively intact individuals confirmed that cognitive decline exacerbates 1- and 2-year mortality following a hip fracture. Furthermore, Bai et al.(26) synthesized 18 cohort studies in a meta-analysis, concluding that comorbid dementia multiplied the risk of mortality at 1, 6, and 12 months by 1.57, 1.97, and 1.77 times, respectively. In the present cohort, dementia was associated with an over 4-fold increase in the odds of 30-day mortality.

Surgical intervention remains the standard approach for managing hip fractures, as reflected by the 97.2% operation rate in our study. Surgical repair is considered crucial for expediting recovery and facilitating rehabilitation. Conversely, older individuals who are  managed conservatively face heightened mortality risks associated with extended periods of bed rest. Consequently, our finding that surgery is an independent protective factor against early mortality is consistent with clinical expectations.

Regarding adverse events following surgery, at least one medical or surgical complication occurred in 22.2% of our cohort, and multiple complications affected 2.9% of our cohort. The most common medical complications were acute kidney injury and pulmonary embolism, and the most common surgical complication was surgical site infection. As anticipated, the occurrence of these postoperative complications was associated with higher 30-day mortality than in complication-free patients. In their 2019 study, Saul et al.(27) reported complications in 33% of patients, 11.5% of whom had surgical complications. Other reports have identified electrolyte imbalances and anemia as the prevailing non-surgical issues in this patient population(28).

Investigating surgical modalities, Parker and Gurusamy(29) concluded in a 2006 systematic review of 17 studies that total arthroplasty and internal fixation yielded no significant mortality differences in older adults with intracapsular fractures. Likewise, we observed no difference in mortality with respect to operative technique, although the anatomical location of the fracture substantially influenced outcomes. Mortality rates have been shown to be higher among individuals with subtrochanteric and trochanteric fractures relative to those with femoral neck fractures(30). Additionally, extracapsular fractures are broadly recognized to portend worse survival outcomes than intracapsular fractures(31). Ricci et al.(32) also documented elevated mortality rates among patients presenting with subtrochanteric or trochanteric fractures. In line with these findings, our data demonstrated a 15.87-fold increase in the odds of early mortality for patients with pertrochanteric fractures. Moreover, consistent with our own observations, prior research confirms that survival rates are generally more favorable following intracapsular trauma compared to extracapsular events(27).

Within the context of hip fractures, the effect of operative timing on patient survival remains a subject of debate. According to a meta-analysis by Moja et al.(33) delayed intervention correlated with a marked rise in pressure ulcer formation and overall mortality risk. Therefore, the general recommendation is that hip fractures be surgically repaired within a 24- to 48-hour window. Conversely, a 2018 prospective cohort study by Lizaur-Utrilla et al.(34) found no increased risk of mortality or complications when surgery was postponed for two or more days to medically optimize highly comorbid individuals. However, when organizational deficits caused the surgical delay, the researchers noted higher rates of one-year mortality and postoperative adverse events. Within our cohort, the interval between the traumatic event and the operation did not significantly alter 30-day survival outcomes. Given that our institution prioritizes prompt surgical fixation whenever feasible, we hypothesize that any operative delays in our cohort were deliberate measures  to achieve adequate medical stabilization prior to surgery.

Another finding of our study was that patients who experienced early mortality following traumatic hip fracture had higher BUN and creatinine values and lower admission lymphocyte counts. Our findings are consistent with the results of previous studies. Blanco et al.(35) observed higher 30-day mortality in association with low lymphocyte and albumin levels at admission in their prospective cohort study. Another study conducted in our country in 2019 showed that patients who died within the first year following hip fracture repair exhibited a higher baseline neutrophil-to-lymphocyte ratio than survivors(36). A subsequent meta-analysis revealed a significant relationship between the neutrophil-to-lymphocyte ratio and mortality at 1 year after hip fracture repair, but not at 30 days(37). However, in the present study, we determined that for each one-unit decrease in admission lymphocyte count, the odds of early mortality increased by 0.2%. Further research is needed to determine the predictive value of lymphocyte count for short-term mortality when evaluating early preoperative risk factors in hip fracture patients. Moreover, Seyedi et al.(38) demonstrated that patients with high BUN levels (>20 mg/dL) and patients with high creatinine (>1.3 mg/dL) levels had a 3-fold and 2.5-fold higher risk of mortality in the first 3 months, respectively.

Study Limitations

Certain limitations of this study must be acknowledged. First, the analysis was retrospective and included a small number of patients from a single center. Other factors that may be associated with mortality were not analyzed, such as the stage of dementia, malnutrition, and medication use. However, an important strength of this research is its contribution to the literature on predictors of early mortality following geriatric hip fractures in the Turkish population.

Conclusion

Older adults face a substantial risk of mortality following a hip fracture. Operative intervention significantly improved survival, whereas admission lymphopenia, comorbid dementia, and pertrochanteric fracture locations were associated with higher early mortality rates. Therefore, we recommend close monitoring in patients presenting with these specific vulnerabilities.

Ethics

Ethics Committee Approval: Prior to the commencement of the study, formal approval was obtained from the Clinical Research Ethics Committee of Atatürk University Faculty of Medicine (approval no: 06, date: 21.02.2024).
Informed Consent: Retrospective study.

Authorship Contributions

Surgical and Medical Practices: E.Ş., İ.D., Concept: M.K., P.T.T., Design: M.K., İ.D., P.T.T., Data Collection or Processing: B.A., E.Ş., Analysis or Interpretation: Ö.K., Literature Search: B.A., M.K., İ.D., Ö.K., P.T.T., Writing: B.A., M.K., İ.D., Ö.K., P.T.T.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study received no financial support.

References

1
Ensrud KE. Epidemiology of fracture risk with advancing age. J Gerontol A Biol Sci Med Sci. 2013;68:1236-42.
2
Krickl J, Ittermann T, Thannheimer A, et al. The rising problem of hip fractures in geriatric patients-analysis of surgical influences on the outcome. J Pers Med. 2023;13:1271.
3
Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285-9.
4
Cheng SY, Levy AR, Lefaivre KA, Guy P, Kuramoto L, Sobolev B. Geographic trends in incidence of hip fractures: a comprehensive literature review. Osteoporos Int. 2011;22:2575-86.
5
Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407-13.
6
Aharonoff GB, Koval KJ, Skovron ML, Zuckerman JD. Hip fractures in the elderly: predictors of one year mortality. J Orthop Trauma. 1997;11:162-5.
7
Penrod JD, Litke A, Hawkes WG, et al. The association of race, gender, and comorbidity with mortality and function after hip fracture. J Gerontol A Biol Sci Med Sci. 2008;63:867-72.
8
Hasegawa Y, Suzuki S, Wingstrand H. Risk of mortality following hip fracture in Japan. J Orthop Sci. 2007;12:113-7.
9
Ireland AW, Kelly PJ, Cumming RG. Risk factor profiles for early and delayed mortality after hip fracture: analyses of linked Australian department of veterans’ affairs databases. Injury. 2015;46:1028-35.
10
Härstedt M, Rogmark C, Sutton R, Melander O, Fedorowski A. Impact of comorbidity on 6-month hospital readmission and mortality after hip fracture surgery. Injury. 2015;46:713-8.
11
Uzoigwe CE, Burnand HG, Cheesman CL, Aghedo DO, Faizi M, Middleton RG. Early and ultra-early surgery in hip fracture patients improves survival. Injury. 2013;44:726-9.
12
Colais P, Di Martino M, Fusco D, Perucci CA, Davoli M. The effect of early surgery after hip fracture on 1-year mortality. BMC Geriatr. 2015;15:141.
13
Aqil A, Hossain F, Sheikh H, Aderinto J, Whitwell G, Kapoor H. Achieving hip fracture surgery within 36 hours: an investigation of risk factors to surgical delay and recommendations for practice. J Orthop Traumatol. 2016;17:207-13.
14
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
15
Hawkes WG, Wehren L, Orwig D, Hebel JR, Magaziner J. Gender differences in functioning after hip fracture. J Gerontol A Biol Sci Med Sci. 2006;61:495-9.
16
Cree M, Soskolne CL, Belseck E, et al. Mortality and institutionalization following hip fracture. J Am Geriatr Soc. 2000;48:283-8.
17
Ensrud KE, Ewing SK, Taylor BC, et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci. 2007;62 744-51.
18
Hamerman D. Toward an understanding of frailty. Ann Intern Med. 1999;130:945-50.
19
Ferrucci L, Guralnik JM, Studenski S, et al. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. 2004;52:625-34.
20
Miller RR, Cappola AR, Shardell MD, et al. Persistent changes in interleukin-6 and lower extremity function following hip fracture. J Gerontol A Biol Sci Med Sci. 2006;61:1053-8.
21
Wehren LE, Hawkes WG, Orwig DL, Hebel JR, Zimmerman SI, Magaziner J. Gender differences in mortality after hip fracture: the role of infection. J Bone Miner Res. 2003;18:2231-7.
22
Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20:1633-50.
23
Ruggiero C, Bonamassa L, Pelini L, et al. Early post-surgical cognitive dysfunction is a risk factor for mortality among hip fracture hospitalized older persons. Osteoporos Int. 2017;28:667-75.
24
Ha YC, Cha Y, Yoo JI, Lee J, Lee YK, Koo KH. Effect of dementia on postoperative mortality in elderly patients with hip fracture. J Korean Med Sci. 2021;36:e238.
25
Lai YC, Tang PL, Kuo TJ, Hsu CJ. Different impacts of dementia on two-year mortality after osteosynthesis and hemiarthroplasty in treating geriatric hip fractures. Arch Gerontol Geriatr. 2018;79:116-22.
26
Bai J, Zhang P, Liang X, Wu Z, Wang J, Liang Y. Association between dementia and mortality in the elderly patients undergoing hip fracture surgery: a meta-analysis. J Orthop Surg Res. 2018;13:298.
27
Saul D, Riekenberg J, Ammon JC, Hoffmann DB, Sehmisch S. Hip fractures: therapy, timing, and complication spectrum. Orthop Surg. 2019;11:994-1002.
28
Barceló M, Torres OH, Mascaró J, Casademont J. Hip fracture and mortality: study of specific causes of death and risk factors. Arch Osteoporos. 2021;16:15.
29
Parker MJ, Gurusamy K. Internal fixation versus arthroplasty for intracapsular proximal femoral fractures in adults. Cochrane Database Syst Rev. 2006;2006:CD001708.
30
Pereira SR, Puts MT, Portela MC, Sayeg MA. The impact of prefracture and hip fracture characteristics on mortality in older persons in Brazil. Clin Orthop Relat Res. 2010;468:1869-83.
31
Johnston AT, Barnsdale L, Smith R, Duncan K, Hutchison JD. Change in long-term mortality associated with fractures of the hip: evidence from the scottish hip fracture audit. J Bone Joint Surg Br. 2010;92:989-93.
32
Ricci G, Longaray MP, Gonçalves RZ, Neto Ada S, Manente M, Barbosa LB. Evaluation of the mortality rate one year after hip fracture and factors relating to diminished survival among elderly people. Rev Bras Ortop. 2015;47:304-9.
33
Moja L, Piatti A, Pecoraro V, et al. Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients. PLoS ONE. 2012;7:e46175.
34
Lizaur-Utrilla A, Gonzalez-Navarro B, Vizcaya-Moreno MF, Miralles Muñoz FA, Gonzalez-Parreño S, Lopez-Prats FA. Reasons for delaying surgery following hip fractures and its impact on one year mortality. Int Orthop. 2019;43:441-8.
35
Blanco JF, da Casa C, Pablos-Hernández C, González-Ramírez A, Julián-Enríquez JM, Díaz-Álvarez A. 30-day mortality after hip fracture surgery: influence of postoperative factors. PLoS One. 2021;16:e0246963.
36
Temiz A, Ersözlü S. Admission neutrophil-to-lymphocyte ratio and postoperative mortality in elderly patients with hip fracture. Ulus Travma Acil Cerrahi Derg. 2019;25:71-4.
37
Chen YH, Chou CH, Su HH, et al. Correlation between neutrophil-to-lymphocyte ratio and postoperative mortality in elderly patients with hip fracture: a meta-analysis. J Orthop Surg Res. 2021;16:681.
38
Seyedi HR, Mahdian M, Khosravi G, et al. Prediction of mortality in hip fracture patients: role of routine blood tests. Arch Bone Jt Surg. 2015;3:51-5.